Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Liver Cancer > Volume 13(1); 2013 > Article
Case Report A Case of Unresectable Hepatocellular Carcinoma Treated by Repeated Transcatheter Arterial Chemoembolization Using DC beads® Followed with Resection
Jeong-Yeop Song1, Young Seok Kim1, Jae Myeong Lee4, Soo Ji Jin5, Kyu Sung Choi6, Yun Nah Lee1, Sang Hyune Kim1, Sung Won Jeong2, Jae Young Jang2, Sae Hwan Lee3, Hong Soo Kim3, Boo Sung Kim3
Journal of Liver Cancer 2013;13(1):65-69
DOI: https://doi.org/10.17998/jlc.13.1.65
Published online: February 28, 2013
  • 696 Views
  • 6 Download
  • 0 Crossref
  • 0 Scopus
1Digestive Disease Center and Research Institute, Department of Internal Medicine Soonchunhyang University College of Medicine, Bucheon Hospital, Bucheon, Korea
2Digestive Disease Center and Research Institute, Department of Internal Medicine Soonchunhyang University College of Medicine, Seoul Hospital, Seoul, Korea
3Digestive Disease Center and Research Institute, Department of Internal Medicine Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea
4Departments of Radiology, Soonchunhyang University College of Medicine, Bucheon, Korea
5Departments of Pathology, Soonchunhyang University College of Medicine, Bucheon, Korea
6Departments of General Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea
Corresponding author:  Young Seok Kim,
Email: liverkys@schmc.ac.kr

In patients with unresectable hepatocellular carcinoma (HCC) and no anti-cancer treatment, the prognosis is quite poor. But in some cases, repeated sessions of transcatheter arterial chemoembolization (TACE) reduce the tumor size even to resectable, and post-TACE resection may prolong the survival time. We present a case of 50-year-old HBV carrier woman with abdominal distension. The diagnosis was huge HCC with intrahepatic metastasis. Repeated intra-arterial injections of adriamycin mixed lipiodol or DC beads® (100-300/300-500/500-700 μm, ©BIOCOMPATIBLES UK LTD) were instituted through ten sessions for 13 months. The tumor size became reduced with a partial response after 10th TACE and post-TACE resection was performed. No visible HCCs and decreased tumor markers were noted on the examinations 3 months after the resection.


JLC : Journal of Liver Cancer